Bevacizumab, 5 mg

Bevacizumab is supplied to meet the demands of controlled research workflows, a monoclonal antibody with the molecular formula C16H21NO3 and a molecular weight of 275.34. It belongs to the immunoglobulin G family, specifically IgG1 kappa, exhibiting high affinity for vascular endothelial growth factor A (VEGF-A) and VEGF-B. This compound is categorized as a warning substance due to potential harm if ingested, as indicated by the hazard statement "Harmful if swallowed." Bevacizumab is primarily used in targeted cancer therapies, inhibiting angiogenesis, a process essential for tumor growth and metastasis.

• CAS Number: 216974-75-3
• Molecular Weight: 275.34
• Molecular Formula: C16H21NO3
• GHS Signal Word: Warning
• Exact Mass: 275.15214353
• Hazard Statements:
• H302: Harmful if swallowed [Warning Acute toxicity, oral]